Enlicitide has the potential to be the first approved oral PCSK9 inhibitor designed to deliver antibody-like efficacy and help address critical unmet needs for patients with HeFH to help combat the ...

Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Adults with Heterozygous Familial Hypercholesterolemia (HeFH) in Phase 3 CORALreef HeFH Trial ...

RAHWAY, N.J., November 09, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 ...

RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the ...

Please provide your email address to receive an email when new articles are posted on . Lorazepam and haloperidol can significantly decrease agitation related to end-of-life delirium for patients with ...

While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

Us Weekly has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! If you’re tired of using makeup to conceal fine lines, wrinkles and blemishes, ...

Whether it’s sunscreens, sheet masks or serums, Korean beauty has a firm grip on the skin care scene (and for good reason). But one element of K-beauty you may not be as familiar with are ampoules, ...

Older age is a primary risk factor for both the incidence and earlier onset of tardive dyskinesia. There is no established minimum duration of dopamine antagonist required to differentiate between ...

Here are six new shortages and discontinuations for April, according to drug supply databases from the FDA and the American Society of Health-System Pharmacists. Editor’s note: The drugs listed are in ...